tak 603 has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, A; Kawamura, N; Makino, H; Ohta, Y; Sohda, T; Taketomi, S | 1 |
| Baba, A; Makino, H; Nishimura, A; Notoya, K; Oda, T; Sohda, T; Taketomi, S | 1 |
2 other study(ies) available for tak 603 and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Studies on disease-modifying antirheumatic drugs: synthesis of novel quinoline and quinazoline derivatives and their anti-inflammatory effect.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Bone Resorption; Dinoprostone; Disease Models, Animal; Female; Magnetic Resonance Spectroscopy; Male; Pregnancy; Quinazolines; Quinolines; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Structure-Activity Relationship | 1996 |
Studies on disease-modifying antirheumatic drugs. III. Bone resorption inhibitory effects of ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl) quinoline-3-carboxylate (TAK-603) and related compounds.
Topics: Animals; Antirheumatic Agents; Bone and Bones; Bone Resorption; Calcium Radioisotopes; Female; Mice; Mice, Inbred C3H; Mice, Inbred ICR; Organ Culture Techniques; Osteoclasts; Ovariectomy; Quinolines; Rats; Rats, Sprague-Dawley; Triazoles | 1999 |